Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-19-001927

Options or other derivatives

  • Chief Executive Officer acquired 525,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hatfield Jeffrey S. · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-01-22 Grant or award : show line 1 in the form Stock Option (Right to Buy) +525,000 525,000 D
Loading xslF345X03/doc4.xml…